Tatva Chintan Pharma Chem Limited Share Price Bombay S.E.

Equities

TATVA

INE0GK401011

Specialty Chemicals

Market Closed - Bombay S.E. 03:30:51 07/05/2024 pm IST 5-day change 1st Jan Change
1,198 INR -1.37% Intraday chart for Tatva Chintan Pharma Chem Limited -2.49% -25.22%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 3.94B 47.17M Sales 2025 * 5.19B 62.24M Capitalization 28.03B 336M
Net income 2024 304M 3.64M Net income 2025 * 513M 6.15M EV / Sales 2024 6.41 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 5.4 x
P/E ratio 2024
81.3 x
P/E ratio 2025 *
54.7 x
Employees 608
Yield 2024 *
0.13%
Yield 2025 *
0.28%
Free-Float 27.98%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Tatva Chintan Pharma Chem Limited, Q4 2024 Earnings Call, May 03, 2024
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Certain Equity Shares of Tatva Chintan Pharma Chem Limited are subject to a Lock-Up Agreement Ending on 25-FEB-2024. CI
Transcript : Tatva Chintan Pharma Chem Limited, Q3 2024 Earnings Call, Jan 20, 2024
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : Tatva Chintan Pharma Chem Limited, Q2 2024 Earnings Call, Nov 02, 2023
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Crisil Affirms A- Rating on Tatva Chintan Pharma Chem's Debt Financing; Outlook Stable MT
Transcript : Tatva Chintan Pharma Chem Limited, Q1 2024 Earnings Call, Aug 04, 2023
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Tatva Chintan Pharma Chem's Consolidated Profit Shrinks in Fiscal Q4 MT
Transcript : Tatva Chintan Pharma Chem Limited, Q4 2023 Earnings Call, May 05, 2023
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
More news
1 day-1.37%
1 week-2.49%
Current month-2.50%
1 month-6.75%
3 months-7.64%
6 months-17.81%
Current year-25.22%
More quotes
1 week
1 195.00
Extreme 1195
1 280.00
1 month
1 195.00
Extreme 1195
1 319.40
Current year
1 063.35
Extreme 1063.35
1 634.20
1 year
1 063.35
Extreme 1063.35
1 888.05
3 years
1 063.35
Extreme 1063.35
2 975.55
5 years
1 063.35
Extreme 1063.35
2 975.55
10 years
1 063.35
Extreme 1063.35
2 975.55
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 12/96/12
Director of Finance/CFO - 03/21/03
Chief Administrative Officer - 21/15/21
Members of the board TitleAgeSince
Director/Board Member 63 27/21/27
Chief Executive Officer 51 12/96/12
Director/Board Member 52 12/96/12
More insiders
Date Price Change Volume
07/24/07 1,198 -1.37% 3 555
06/24/06 1,215 -2.46% 5,308
03/24/03 1,246 +1.51% 839
02/24/02 1,227 -0.15% 1,912
30/24/30 1,229 +0.00% 475

Delayed Quote Bombay S.E., May 07, 2024 at 03:30 pm IST

More quotes
Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is engaged in the manufacturing of verity of chemicals include structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). Its SDAs are quarternary salts, which helps in the formation of channels and pores during the synthesis of zeolites. Its PTCs are used to facilitate the migration of a reactant from one phase into another phase where the reaction occurs in a heterogeneous multi-phase system. The Company operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. The Company is focused on serving various customers across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavors and fragrances industries.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,215 INR
Average target price
1,674 INR
Spread / Average Target
+37.82%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW